Free Trial
NASDAQ:MLEC

Moolec Science Q1 2025 Earnings Results & Report

Moolec Science logo
$1.87 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.78 -0.10 (-5.08%)
As of 04:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Moolec Science met analyst earnings expectations and beat on revenue in its Q1 2025 results, released April 16, 2025. The company reported EPS of -$9.00 versus the -$9.00 consensus estimate, while revenue of $2.64 million topped the $2.01 million estimate by $0.63 million.

Earnings Announcement Details

Quarter
Q1 2025
Report Date
Time
Before Market Opens

Moolec Science EPS Results

Actual EPS
-$9.00
Consensus EPS
-$9.00
Beat/Miss
Met Expectations
One Year Ago EPS
N/A
EPS Beat Rate
1 of last 4 quarters

Moolec Science Revenue Results

Actual Revenue
$2.64 million
Expected Revenue
$2.01 million
Beat/Miss
Beat by +$633.00 thousand
YoY Revenue Growth
N/A

Conference Call Resources

Moolec Science Q1 2025 Earnings FAQ

Moolec Science (NASDAQ:MLEC) reported earnings of -$9.00 per share for Q1 2025, matching the consensus estimate of -$9.00. The report was announced on Wednesday, April 16, 2025.

Moolec Science reported revenue of $2.64 million for Q1 2025, against a consensus estimate of $2.01 million.

Moolec Science Earnings Headlines

Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
MLEC Share News Today
See More Moolec Science Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Moolec Science? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Moolec Science and other key companies, straight to your email.

About Moolec Science

Moolec Science (NASDAQ:MLEC) Ltd. is a food-technology and biotechnology company developing alternative sources of animal proteins through molecular farming. The company uses genetically engineered plants, including soybeans and safflower, as biological production platforms designed to produce specific proteins that can be used in food and other applications.

Its research and development programs have included “Piggy Sooy,” a soybean engineered to produce pork protein, as well as safflower-based production of animal proteins such as chymosin, an enzyme used in cheese manufacturing. Moolec’s approach is intended to support the production of animal-derived ingredients with potentially lower resource requirements than conventional livestock-based methods.

Moolec was founded in 2020 and has developed activities connected with biotechnology and agricultural research in the United States and South America. The company is led by Chief Executive Officer Gastón Paladini, who is associated with the Paladini food group and has experience in the food industry. Moolec Science is listed on the Nasdaq under the symbol MLEC.

View Moolec Science Profile